Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 63 Breast Neoplasms 28 Neoplasms 5 Neoplasm Metastasis 3 Leiomyoma 3 Cardiovascular Diseases 3 Polycystic Ovary Syndrome 2 Neoplasms by Site 2 Endometrial Neoplasms 2 Breast Diseases 2 Advanced Breast Cancer 2 Stage II Prostate Adenocarcinoma 1 Sleep Wake Disorders 1 Skin Diseases 1 Sexual Dysfunctions, Psychological 1 Sarcopenia 1 Salivary Gland Neoplasms 1 Salivary Gland Adenoma, Pleomorphic 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatectomy 1 Prostate Cancer With ≤10 Bone Metastases 1 Prostate Cancer Metastatic Disease 1 Prostate Cancer Metastatic 1 Pelvic Pain 1 Ovarian Neoplasms 1 Osteoporosis 1 Oligometastatic Prostate Carcinoma 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Metastatic Neuroendocrine Prostate Cancer 1

Interventions

Exercise 35 Therapeutics 30 Modafinil 21 Yoga 17 Surveys and Questionnaires 16 Methylphenidate 16 Psychiatric Rehabilitation 14 Acupuncture Therapy 11 Educational Status 9 Walking 8 Early Intervention, Educational 8 Cognitive Behavioral Therapy 8 Ultraviolet Therapy 7 Control Groups 7 Therapeutic Touch 6 Physical Therapy Modalities 6 Mental Status and Dementia Tests 6 Exercise Therapy 6 Acceptance and Commitment Therapy 6 Sugars 5 Qigong 5 Palliative Care 5 Counseling 5 Standard of Care 4 Saline Solution 4 Methods 4 Epoetin Alfa 4 Dexamethasone 4 Behavior Therapy 4 Acupressure 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Fatigue × Gonadotropin-Releasing Hormone × Clear all

NCT00659373 2016-07-25

Co-SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed

86 enrolled 4 charts

Breast Neoplasms, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡